These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28586026)

  • 1. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
    Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
    Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
    Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
    Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
    Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9: An anticancer molecule for gallbladder carcinoma.
    Tadokoro T; Morishita A; Fujihara S; Iwama H; Niki T; Fujita K; Akashi E; Mimura S; Oura K; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Himoto T; Hirashima M; Masaki T
    Int J Oncol; 2016 Mar; 48(3):1165-74. PubMed ID: 26797414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells.
    Kono T; Fujihara S; Oura K; Iwama H; Fujita K; Fujita N; Takuma K; Ono M; Namima D; Yamana H; Chiyo T; Kobayashi K; Kamada H; Kobara H; Ono M; Niki T; Hirashima M; Masaki T
    Anticancer Res; 2023 Aug; 43(8):3769-3777. PubMed ID: 37500141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
    Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
    Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
    Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
    Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
    Adams O; Janser FA; Dislich B; Berezowska S; Humbert M; Seiler CA; Kroell D; Slotta-Huspenina J; Feith M; Ott K; Tschan MP; Langer R
    PLoS One; 2018; 13(6):e0197610. PubMed ID: 29897944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo.
    Piazuelo E; Esquivias P; De Martino A; Cebrián C; Conde B; Santander S; Emperador S; García-González MA; Carrera-Lasfuentes P; Lanas A
    Dig Dis Sci; 2016 Oct; 61(10):2896-2907. PubMed ID: 27343037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model.
    Chiyo T; Fujita K; Iwama H; Fujihara S; Tadokoro T; Ohura K; Matsui T; Goda Y; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Kobara H; Mori H; Niki T; Hirashima M; Himoto T; Masaki T
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
    Fujihara S; Kato K; Morishita A; Iwama H; Nishioka T; Chiyo T; Nishiyama N; Miyoshi H; Kobayashi M; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
    Int J Oncol; 2015 May; 46(5):2172-80. PubMed ID: 25709052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
    Mari L; Hoefnagel SJM; Zito D; van de Meent M; van Endert P; Calpe S; Sancho Serra MDC; Heemskerk MHM; van Laarhoven HWM; Hulshof MCCM; Gisbertz SS; Medema JP; van Berge Henegouwen MI; Meijer SL; Bergman JJGHM; Milano F; Krishnadath KK
    Gastroenterology; 2018 Sep; 155(3):784-798. PubMed ID: 29885883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma.
    Lin S; Liu K; Zhang Y; Jiang M; Lu R; Folts CJ; Gao X; Noble MD; Zhao T; Zhou Z; Lan X; Que J
    Cell Signal; 2018 Nov; 51():222-232. PubMed ID: 30102978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
    Goltsov AA; Fang B; Pandita TK; Maru DM; Swisher SG; Hofstetter WL
    Ann Thorac Surg; 2018 Feb; 105(2):363-370. PubMed ID: 29223420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of full-length adiponectin and proinflammatory effect of globular adiponectin in esophageal adenocarcinoma cells.
    Zhang R; Wu J; Liu D; Shan H; Zhang J
    Oncol Res; 2013; 21(1):15-21. PubMed ID: 24330848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance.
    Derouet MF; Liu G; Darling GE
    PLoS One; 2014; 9(12):e115589. PubMed ID: 25551563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.
    Feingold PL; Surman DR; Brown K; Xu Y; McDuffie LA; Shukla V; Reardon ES; Crooks DR; Trepel JB; Lee S; Lee MJ; Gao S; Xi S; McLoughlin KC; Diggs LP; Beer DG; Nancarrow DJ; Neckers LM; Davis JL; Hoang CD; Hernandez JM; Schrump DS; Ripley RT
    Mol Cancer Ther; 2018 Sep; 17(9):2013-2023. PubMed ID: 29934340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.
    Weh KM; Howell AB; Kresty LA
    Mol Carcinog; 2016 Nov; 55(11):1876-1885. PubMed ID: 27696537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation.
    Liu D; Zhang R; Wu J; Pu Y; Yin X; Cheng Y; Wu J; Feng C; Luo Y; Zhang J
    Oncol Rep; 2017 Mar; 37(3):1779-1785. PubMed ID: 28184939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.